Today, the Food and Drug Administration (FDA) and the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) announced their intent to continue in a cooperative effort to address the manufacturing quality concerns related to the production of Chiron's influenza vaccine, Fluvirin, at the company's Liverpool facility.
Regarding the ongoing joint effort, FDA Acting Commissioner Lester M. Crawford said, "The decision to work cooperatively to evaluate the scope of contamination and evidence presented in Chiron's investigation report is a significant positive step to understand fully what is at issue with influenza vaccines from Chiron's 2004 production. In addition, this effort will help to successfully address any significant issues before production for 2005 begins."
MHRA officials have been accompanying the FDA inspectors as observers in FDA's ongoing facility inspection of Chiron's plant. The inspection follows MHRA's Sept. 28-30, 2004 inspection of the facility and subsequent announcement on October 5 to suspend Chiron's license.
MHRA Chief Executive Officer, Prof. Kent Woods, added, "Contrary to some reported statements, MHRA, as the responsible regulatory authority in the United Kingdom, made the decision to suspend Chiron's license after an internal meeting on October 4 and first informed the company and the FDA of this decision on October 5. At the same time, we informed other drug regulatory authorities via an intergovernmental rapid information alert."
Chiron officials confirmed that they were first informed of the license suspension on October 5. A primary objective of the ongoing FDA investigation that commenced on October 10 is to evaluate Chiron's own internal investigation and findings concerning the contamination of some lots and its manufacturing quality systems related to assuring sterility of final vaccine product.
Source: FDA
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
Broadening the Path: Diverse Educational Routes Into Infection Prevention Careers
July 4th 2025Once dominated by nurses, infection prevention now welcomes professionals from public health, lab science, and respiratory therapy—each bringing unique expertise that strengthens patient safety and IPC programs.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.